Monroe Capital (MRCC) sees over 5% stake reported by Goldstein
Rhea-AI Filing Summary
Monroe Capital received a Schedule 13G filing from Bulldog Investors, LLP, Phillip Goldstein, and Andrew Dakos reporting passive ownership of its common stock as of December 31, 2025. Bulldog Investors reports beneficial ownership of 1,016,123 shares, or 4.69% of the outstanding common stock.
Phillip Goldstein reports beneficial ownership of 1,128,192 shares, or 5.21%, while Andrew Dakos reports 954,816 shares, or 4.41%. The filers certify the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Monroe Capital.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the Schedule 13G filing for Monroe Capital (MRCC) disclose?
The Schedule 13G shows Bulldog Investors, Phillip Goldstein, and Andrew Dakos collectively reporting significant beneficial ownership of Monroe Capital common stock as of December 31, 2025, with holdings ranging from 4.41% to 5.21% of the company’s outstanding common stock.
What is Phillip Goldstein’s ownership stake in Monroe Capital (MRCC)?
Phillip Goldstein reports beneficial ownership of 1,128,192 Monroe Capital common shares, equal to 5.21% of the class. He has sole voting and dispositive power over 61,307 shares and shared voting and dispositive power over 1,066,885 additional shares.
Is the Bulldog Investors position in Monroe Capital (MRCC) passive or activist?
The filing characterizes the position as passive. The reporting persons certify the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Monroe Capital, consistent with Schedule 13G requirements.